Proven Lab-grade Results Without the Lab
Sight OLO provides 5-part CBC results with 19 parameters and sophisticated flagging capabilities at the point of care. It is the first CBC analyzer that is FDA 510(k) cleared for blood taken directly from either a finger prick or a venous sample.
Suitable For Any Clinical Settings
Sight OLO has been validated for patients aged 3 month and above in a variety of clinical settings such as oncology, pediatrics and urgent care settings. The possibility of processing finger prick samples in a field hospital or remote clinics makes Sight OLO perfectly accessible to the most delicate patients and situations.
Minimal Blood Volume Required.
Results in Minutes.
Each test requires just 2 drops of blood from a finger prick or a venous sample. The sample preparation process can be completed in under one minute, with the full results ready in minutes on touchscreen interface, printout, email or via LIS/middleware.
Simple to Set-up and Operate
Sight OLO is perfectly suited for point of care settings. It comes factory calibrated for a quick set-up and requires no maintenance or manual QC. Its minimal training and step-by-step on-screen guidance are designed to be used by operators with any level of experiences. OLO also has an Operator Management feature that allows for complete control over who can access the device, including traceability of operator activities.
No Mess, No Stress
Sight OLO can be placed on any stable surface. It uses a disposable cartridge per test, eliminating the need for reagent procurement, storage and liquid waste disposal. The analyzer can be operated between 18 and 30 degrees Celsius and the test kit can be stored between 18 and 26 degrees Celsius.
Unprecedented Breakthrough in Blood Diagnostics
Sight OLO represents a culmination of cutting edge innovations in physics, optics, sample preparation and AI based computer vision algorithms. This breakthrough allowed Sight to be recognized as one of The World’s Most Innovative Companies in 2019 by Fast Company.
There are no reviews yet.